Evolent Health, Inc. (EVH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bright Horizons Family Solutions, Inc.

Remitly Global, Inc.

Progyny, Inc.

Concentrix Corp.

MAXIMUS, Inc.

The Brink's Co.

ADT, Inc.

Grand Canyon Education, Inc.

Clarivate Plc

Shift4 Payments, Inc.

Evolent Health, Inc.

Why is Evolent Health, Inc. ?

Poor Management Efficiency with a low ROCE of 0.44%

The company has been able to generate a Return on Capital Employed (avg) of 0.44% signifying low profitability per unit of total capital (equity and debt)

The company has declared negative results for the last 3 consecutive quarters

PRE-TAX PROFIT(Q) At USD -7.73 MM has Fallen at -355.12%
NET PROFIT(Q) At USD -6.9 MM has Fallen at -311.27%
OPERATING CASH FLOW(Y) Lowest at USD -33.32 MM

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -66.61%, its profits have fallen by -7350%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -66.61% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Evolent Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Evolent Health, Inc.

-65.16%

-1.23

67.94%

S&P 500

13.22%

0.64

20.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.43%

EBIT Growth (5y)

12.93%

EBIT to Interest (avg)

-0.03

Debt to EBITDA (avg)

3.44

Net Debt to Equity (avg)

0.84

Sales to Capital Employed (avg)

1.11

Tax Ratio

0.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

0.44%

ROE (avg)

1.93%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.06

EV to EBIT

-1050.09

EV to EBITDA

15.47

EV to Capital Employed

1.03

EV to Sales

0.74

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.10%

ROE (Latest)

-8.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -50.41% (YoY

-37What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -7.73 MM has Fallen at -355.12%

NET PROFIT(Q)

At USD -6.9 MM has Fallen at -311.27%

OPERATING CASH FLOW(Y)

Lowest at USD -33.32 MM

ROCE(HY)

Lowest at -13.38%

INTEREST COVERAGE RATIO(Q)

Lowest at 234.92

DEBT-EQUITY RATIO (HY)

Highest at 101.19 %

NET SALES(Q)

Lowest at USD 444.33 MM

INTEREST(Q)

Highest at USD 11.6 MM

Here's what is working for Evolent Health, Inc.

Raw Material Cost

Fallen by -50.41% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Evolent Health, Inc.

Net Sales

At USD 444.33 MM has Fallen at -31.34%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -7.73 MM has Fallen at -355.12%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -6.9 MM has Fallen at -311.27%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 11.6 MM has Grown at 11.71%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest Coverage Ratio

Lowest at 234.92

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at USD -33.32 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales

Lowest at USD 444.33 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Interest

Highest at USD 11.6 MM

in the last five periods and Increased by 11.71% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 101.19 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio